Latest Breaking News On - Talent philosophy - Page 1 : comparemela.com
Creating A Culture Of Innovation And Inclusivity At Avantor: Developing Our Associates
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.
Creating a Culture of Innovation and Inclusivity at Avantor: Developing Our Associates
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
People, Passion, and Possibilities: AbbVie’s Vision of Patient-Centric Healthcare By acquiring Allergan during the pandemic last year, AbbVie became the world’s fourth largest pharmaceutical company.
Last May, research-based global biopharmaceutical firm AbbVie finalized a transformative acquisition of Allergan, an Ireland-headquartered healthcare solutions provider. The transaction made AbbVie, a relatively young spinoff of the long-established Abbott Laboratories, the fifth largest biopharmaceutical company in the world. It further diversified the company’s robust product portfolio, expanded and strengthened its already robust R&D pipeline, and allowed AbbVie to offer innovative treatments to an even larger patient population that spans over 175 countries.
The Straits Times
Singaporeans are an integral part of this global biopharmaceutical company They are developed as part of AbbVie’s global and diverse workforce that produce medicines for more than 50 million patients annually
PublishedApr 13, 2021, 4:00 am SGT
https://str.sg/JyN7
They can read the article in full after signing up for a free account.
Share link:
Or share via:
Sign up or log in to read this article in full
Sign up
All done! This article is now fully available for you
Read now
Get unlimited access to all stories at $0.99/month for the first 3 months.
Get unlimited access to all stories at $0.99/month for the first 3 months.
vimarsana © 2020. All Rights Reserved.